Study of advanced rheumatoid arthritis

I n December 2011, the Brazilian Journal of Rheumatology (BJR) published the article “Anti-citrullinated peptide antibodies and rheumatoid factor in Sudanese patients with

Radiographic, clinical and functional outcomes of treatment with adalimumab (a human anti- tumor necrosis factor monoclonal antibody) in patients with active rheumatoid

ABSTRACT: The paper entitled Ahlin E, Elshafei A, Nur M, El Sai SH, Johan R, Elghazali G. Anti-citrullinated peptide antibodies and rheumatoid factor in Sudanese patients

1 – Graph showing the percentage of patients with rheumatoid factor or positive or negative anti-CCP antibody, among SSc patients without arthritis, SSc with arthritis, and

Comparative study of elderly onset rheumatoid arthritis and young onset rheumatoid arthritis in a Colombian population: clinical, laboratory and HLA DR B1 findings. Clin

Anti-cyclic citrullinated peptide (anti-CCP), anti-mutated citrullinated vimentin (anti-MCV) and IgA-rheumatoid factor (RF) were deter- mined by ELISA and IgM-RF by latex

Anticyclic citrullinated peptide antibody and rheumatoid factor in South Tunisian patients with rheumatoid arthritis: association with disease activity and severity. Farid SSh, Azizi

OBJECTIVE: To perform an association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope, and smoking status